"Cardiorenal Syndrome" and Strategies for Improving Heart and Kidney Function in the Patient with CHF and Kidney Disease
Omar F. Abou Ezzeddine, M.D., C.M., M.S.
Eddie L. Greene, M.D.

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

• Describe the underlying pathophysiological mechanisms and interactions involved in the development of volume overload in the setting concomitantly compromised cardiac/renal function ("Cardiorenal Syndrome") in the patient with both cardiovascular disease and kidney disease
• Describe new strategies that are effective in reducing volume overload and congestion to improve both cardiac and kidney function while limiting the stimulation of adverse neuro-hormonal signals

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.